CLINICAL_TRIALS
trial_result
· 2010-01-27
Clinical Trial Update: Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects [Phase 2]
Summary
Phase 2 trial assessing antiviral activity and safety of two doses of mifepristone in HIV-1 infected subjects.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VGX Pharmaceuticals, LLC | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2010-01-27